Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
06/1998
06/25/1998WO1998027093A1 Combinatorial process for preparing hydrofuroquinoline libraries
06/25/1998WO1998027070A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
06/25/1998WO1998026768A2 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith
06/25/1998WO1998019649A3 Methods and compositions for inhibition of angiogenesis
06/25/1998DE19652763A1 New carbocyclic and heterocyclic carboxylic acid or tetrazolyl compounds
06/25/1998CA2275256A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
06/25/1998CA2274892A1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections andthe gastroduodenal diseases associated therewith
06/25/1998CA2273884A1 Combinatorial process for preparing hydrofuroquinoline libraries
06/24/1998EP0849267A1 Furoindolizines
06/24/1998CN1185786A Sugar-modified cytostatics
06/24/1998CN1185781A Fused polycyclic heterocycle derivatives
06/24/1998CN1185742A Protein kinase c inhibitors
06/23/1998US5770730 Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
06/23/1998US5770605 Method for treating leukemia with a hexa-cyclic compound
06/23/1998US5770598 Antitumor agents; reacting with carbonyl diimidazole and amidoximes
06/23/1998CA2176506C Substituted oxindoles
06/23/1998CA2086968C Quinazoline derivatives
06/18/1998WO1998025928A1 Substituted phenylketoenols and their use as pesticides and herbicides
06/18/1998WO1998025901A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998WO1998025900A1 Compounds having antitumor activity
06/18/1998WO1998025611A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
06/18/1998WO1998025605A1 Spiro-substituted azacycles as modulators of chemokine receptor activity
06/18/1998DE19652219A1 Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen Use of 7- (1-Aminomethyl-2-oxa-7-azabicyclo [3.3.0] oct-7-yl) -chinolon- and naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith
06/18/1998DE19651686A1 Neue substituierte Phenylketoenole New substituted Phenylketoenole
06/18/1998CA2274898A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998CA2225209A1 Ucs1025 compounds
06/17/1998EP0848027A2 Mixtures of cyclic oligocarbonates, process for their preparation and use thereof
06/17/1998EP0847992A1 Benzamide derivatives, useful as cell differentiation inducers
06/17/1998EP0847397A1 Novel water-soluble c-ring analogues of 20 (s)-camptothecin
06/11/1998WO1998024806A2 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
06/11/1998WO1998024791A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
06/11/1998WO1998024447A1 Use of nk-1 receptor antagonists for treating cognitive disorders
06/11/1998WO1998024446A1 Use of nk-1 receptor antagonists for treating movement disorders
06/11/1998WO1998024445A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders
06/11/1998WO1998024444A1 Use of nk-1 receptor antagonists for treating substance use disorders
06/11/1998WO1998024443A1 Use of nk-1 receptor antagonists for treating bipolar disorders
06/11/1998WO1998024441A1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety
06/11/1998WO1998024440A1 Use of nk-1 receptor antagonists for treating stress disorders
06/11/1998WO1998024439A1 Use of nk-1 receptor antagonists for treating severe anxiety disorders
06/11/1998WO1998024438A1 Use of nk-1 receptor antagonists for treating major depressive disorders
06/11/1998CA2273856A1 Use of nk-1 receptor antagonists for treating bipolar disorders
06/11/1998CA2273853A1 Use of nk-1 receptor antagonists for treating cognitive disorders
06/11/1998CA2273810A1 Use of nk-1 receptor antagonists for treating major depressive disorders
06/11/1998CA2273809A1 Use of nk-1 receptor antagonists for treating movement disorders
06/11/1998CA2273807A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders
06/11/1998CA2273806A1 Use of nk-1 receptor antagonists for treating substance use disorders
06/11/1998CA2273800A1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety
06/11/1998CA2273786A1 Use of nk-1 receptor antagonists for treating stress disorders
06/11/1998CA2273785A1 Use of nk-1 receptor antagonists for treating severe anxiety disorders
06/11/1998CA2272548A1 Serine protease inhibitors
06/11/1998CA2272330A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
06/10/1998EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
06/10/1998EP0845988A1 Novel fused isoquinolines as dopamine receptor ligands
06/10/1998CN1184481A Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
06/10/1998CN1184423A Nodulisporic acid derivatives
06/09/1998US5763612 Benzopyran dyes and their intermediates
06/09/1998US5763588 Pyrimidine derivatives for labeled binding partners
06/09/1998US5763453 Antitumor agents
06/09/1998US5763451 Dynemicin analogs
06/09/1998US5763355 Potentiation
06/09/1998CA2111223C Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
06/04/1998WO1998023614A1 Novel phenanethridinium derivatives
06/04/1998WO1998009948A3 Nitric ester derivatives and their use in urinary incontinence and other diseases
06/03/1998EP0845464A2 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds as intermediates for camptothecin derivatives
06/03/1998EP0845463A1 Thiazoline derivative
06/03/1998EP0845460A1 PROCESS FOR PRODUCING 4a-ARYLDECAHYDROISOQUINOLINE DERIVATIVES
06/03/1998EP0844998A1 Halobenzimidazoles and their use as microbicides
06/03/1998CN1183773A Alpha-substd. pyrimidine-thioalkyl and alkylether compounds
06/03/1998CN1183414A S type 2 -substituted hydroxy-2 -indolidinylbutyric ester compounds and process for preparation thereof
06/02/1998US5760054 Alpha IC adrenergic receptor antagonists
06/02/1998US5760050 Schizophrenia
06/02/1998US5760036 Enzyme inhibitors of retroviral protease for prevention of aids
06/02/1998CA2005741C Quinoline sulfonoamino compounds having vessel smooth muscle relaxation activity
05/1998
05/28/1998WO1998022467A1 New process for the preparation of morphinans
05/28/1998CA2269910A1 New process for the preparation of morphinans
05/27/1998EP0843671A1 Heterocyclic compounds and pharmaceutical compositions containing them
05/26/1998US5756764 Drug; proteasome inhibitors
05/26/1998US5756756 Intermediates for biotin derivatives
05/26/1998US5756734 Crambescidins: new antiviral and cytotoxic compounds from the sponge crambe crambe
05/26/1998US5756532 Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
05/26/1998US5756512 Treatment of non-small cell lung carcinoma
05/26/1998US5756495 Nervous system disorders; alzheimer's disease
05/26/1998US5756424 Potentiation
05/26/1998US5756320 Culturing microorganisms belonging to the genus streptomyces; isolation; exhibit inhibitory action on interleukin-6
05/22/1998WO1998021211A1 1- and 2-substituted marcfortines and paraherquamides as antiparasitic agents
05/22/1998WO1998021209A1 New imidazopyridines and oxazolopyridines
05/20/1998EP0842923A1 Pyrrole derivatives and medicinal composition
05/20/1998EP0842178A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0636371B1 Antitussive
05/20/1998CN1182428A Fused imidazo £1, 2 a| pyridines
05/20/1998CN1182087A New substituted 7, 12 -dioxabenz £a| anthracene compounds, process for preparing them and pharmaceutical compositions containing them
05/19/1998US5754271 Photochromic dyes for sunglasses and contact lenses
05/19/1998US5753670 Anticoagulants
05/19/1998US5753663 5ht2c antagonist, useful for treating anxiety, pain, obsessive compulsive disorder, alcoholism, depression, migraine, sleep disorder, anorexia nervosa and priapism
05/19/1998US5753660 Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
05/19/1998US5753655 1-arylsulphonyl, arylcarbonyl and arylthiocarbonyl pyridazino derivatives and methods of preparation
05/19/1998US5753594 3-halo-3-hetarylcarboxylic acid derivatives, and processes and intermediates for their preparation
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998019648A2 N-oxy-naphthalimides as antibacterial agents
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 298